Genome-wide epigenetic analysis of Childhood Acute Lymphoblastic Leukaemia

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/607306

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Of all cancers in children, Acute Lymphoblastic Leukaemia is the most common. To date, the causal mechanism(s) for leukaemia in children remain unclear. Although 5-year event-free survival rates are relatively high (up to 80%) it is still unclear why children expected to survive with a good prognosis, succumb to the disease. Therefore, there is still a need to further refine current diagnosis and prognosis parameters that will together lead to improved outcomes to children with leukaemia.

Funded Activity Details

Start Date: 01-01-2010

End Date: 01-01-2011

Funding Scheme: NHMRC Project Grants

Funding Amount: $410,469.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Haematological Tumours

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

Acute Lymphoblastic Leukaemia | Cancer | DNA methylation | Haemotology | Leukaemia | Leukamia in Children | cancer | cancer prognosis | childhood cancer | paediatric oncology

Related Links